This 2016 study assessed the effects of aging on immune response and melanoma-specific survival (MSS) using data from three large cohorts: SEER (n=304,476), IMCG (n=1,241), and TCGA (n=292). Results showed that older patients were more likely to present with thicker, ulcerated tumors and advanced-stage disease, leading to poorer MSS. However,
